ASX:IIQ INOVIQ (IIQ) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About INOVIQ Stock (ASX:IIQ) 30 days 90 days 365 days Advanced Chart Get INOVIQ alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$47.40 millionP/E RatioN/ADividend Yield15.56%Price TargetN/AConsensus RatingN/A Company OverviewINOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.Read More… Receive IIQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INOVIQ and its competitors with MarketBeat's FREE daily newsletter. Email Address IIQ Stock News HeadlinesINOVIQ Ltd Requests Trading Halt Pending Key AnnouncementMay 25 at 10:29 PM | tipranks.comINOVIQ Ltd Expands in Cancer Diagnostics MarketOctober 30, 2024 | tipranks.comF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.May 28, 2025 | The Tomorrow Investor (Ad)INOVIQ Ltd ShareCafe Hidden Gems Webinar TranscriptSeptember 14, 2024 | gurufocus.comINOVIQ Ltd Extraordinary Shareholders Meeting TranscriptSeptember 14, 2024 | gurufocus.comINOVIQ Full Year 2023 Earnings: AU$0.097 loss per share (vs AU$0.20 loss in FY 2022)August 31, 2023 | finance.yahoo.comIIQ.AX - INOVIQ LtdAugust 16, 2023 | finance.yahoo.comEXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TESTAugust 14, 2023 | finance.yahoo.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:IIQ CIKN/A Webwww.inoviq.com Phone61 3 9548 7586FaxN/AEmployees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.55 million Net Margins-1,224.84% Pretax MarginN/A Return on Equity-35.69% Return on Assets-19.70% Debt Debt-to-Equity Ratio2.02 Current Ratio7.07 Quick Ratio9.52 Sales & Book Value Annual Sales$1.56 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.22 per share Price / BookN/AMiscellaneous Outstanding Shares111,530,000Free FloatN/AMarket Cap$47.40 million OptionableNot Optionable Beta2.04 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (ASX:IIQ) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INOVIQ Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share INOVIQ With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.